Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations
    • DRUGS AND BIOLOGICS—U.S.: Supreme Court maintains status quo on mifepristone access pending appeal
    • ADMINISTRATION OF FDC ACT—NOTICES: FDA issues annual compilation of STIC web page updates
    • ADMINISTRATION OF MEDICARE/MEDICAID PROGRAMS—CMS LETTERS: CMS adds new stratification standards to FFY 2027 Core Sets
    • ADMINISTRATION OF MEDICARE/MEDICAID PROGRAMS—GAO REPORTS: CRA applies to WISeR Model Notice
    • ADMINISTRATION OF MEDICARE/MEDICAID PROGRAMS—PRRB DECISIONS: Contractor incorrectly disallowed half-million-dollar bad debt reimbursement to Indiana hospital
    • EXPERT INSIGHTS—Government Contractors, Take Note: Illinois Court Curtails Broad BIPA Exemption
    • FOOD—N.D. Ill.: General causation expert could testify in infant formula dispute where intervening cause arguments did not warrant exclusion
    • GENERAL HEALTH CARE NEWS—CBO REPORTS: CBO releases a report with baseline projections for federal spending on health insurance subsidies from 2026 to 2036
    • MEDICAID—NOTICES: CMS reopens comment period on Medicaid, CHIP data collection after eligibility template error
    • PROGRAM INTEGRITY—NOTICES: CMS imposes nationwide hospice and home health enrollment moratoria as part of antifraud crackdown
    • TOBACCO—FDA GUIDANCE NOTICES: FDA issues final guidance on enforcement priorities for unauthorized tobacco products
    • VETERINARY DRUGS—S.D. Cal.: Horse ointment users’ reproductive injury claims survive motion to strike fraud allegations and request for definite statement
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations

    Health Law Daily Wrap Up, ADMINISTRATION OF FDC ACT—NOTICES: FDA issues annual compilation of STIC web page updates, (May 15, 2026)

    By WK Editorial Staff

    The FDA announced its compilation of 2025 updates to its Susceptibility Test Interpretive Criteria web page, including changes to recognized standards and drug-specific criteria.

    The Food and Drug Administration issued a notice announcing the annual c ...

    By WK Editorial Staff

    The FDA announced its compilation of 2025 updates to its Susceptibility Test Interpretive Criteria web page, including changes to recognized standards and drug-specific criteria.

    The Food and Drug Administration issued a notice announcing the annual compilation of updates to its Susceptibility Test Interpretive Criteria (STIC) web page, as required by the 21st Century Cures Act. The STIC web page, established in 2017, identifies recognized antimicrobial susceptibility test interpretive criteria and is regularly updated to reflect new or revised standards, supporting streamlined premarket review of testing devices. The notice compiles 2025 updates, including changes in recognition of certain standards and revisions to drug-specific interpretive criteria based on standards development organizations and FDA determinations. The FDA also invites public comment on these updates and will consider submitted information when evaluating future changes to recognized standards and criteria (Notice, 91 FR 25894, May 12, 2026).

    Dates. This notice is published in the Federal Register on May 12, 2026.

    FederalRegisterIssuances: Notices FDCActNews DrugBiologicNews MDeviceNews

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use